Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agilon Health (AGL) Gains from Investment Securities (2020 - 2025)

Agilon Health (AGL) has disclosed Gains from Investment Securities for 4 consecutive years, with -$53000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities changed N/A year-over-year to -$53000.0, compared with a TTM value of -$42.0 million through Dec 2025, changed N/A, and an annual FY2025 reading of $5.5 million, changed N/A over the prior year.
  • Gains from Investment Securities was -$53000.0 for Q4 2025 at Agilon Health, down from $2.2 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $2.2 million in Q1 2025 and bottomed at -$43.6 million in Q4 2022.
  • Average Gains from Investment Securities over 3 years is -$7.3 million, with a median of -$304500.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities surged 119.2% in 2021, then crashed 82377.36% in 2022.
  • Year by year, Gains from Investment Securities stood at $53000.0 in 2021, then plummeted by 82377.36% to -$43.6 million in 2022, then surged by 99.88% to -$53000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for AGL at -$53000.0 in Q4 2025, $2.2 million in Q1 2025, and -$43.6 million in Q4 2022.